Programmed Cell Death-1 Deficiency Exacerbates T Cell Activation and Atherogenesis despite Expansion of Regulatory T Cells in Atherosclerosis-Prone Mice by Cochain, Clement et al.
Programmed Cell Death-1 Deficiency Exacerbates T Cell
Activation and Atherogenesis despite Expansion of
Regulatory T Cells in Atherosclerosis-Prone Mice
Cle´ment Cochain1,2., Sweena M. Chaudhari1,2., Miriam Koch1, Heinz Wiendl3, Hans-Henning Eckstein2,4,
Alma Zernecke1,2*
1 Institute of Clinical Biochemistry and Pathobiochemistry, University Hospital Wu¨rzburg, Wu¨rzburg, Germany, 2Department of Vascular Surgery, Klinikum rechts der Isar,
Technical University Munich, Munich, Germany, 3Department of Neurology, University of Mu¨nster, Mu¨nster, Germany, 4DZHK (German Centre for Cardiovascular
Research), partner site Munich Heart Alliance, Munich, Germany
Abstract
T cell activation represents a double-edged sword in atherogenesis, as it promotes both pro-inflammatory T cell activation
and atheroprotective Foxp3+ regulatory T cell (Treg) responses. Here, we investigated the role of the co-inhibitory receptor
programmed cell death-1 (PD-1) in T cell activation and CD4+ T cell polarization towards pro-atherogenic or
atheroprotective responses in mice. Mice deficient for both low density lipoprotein receptor and PD-1 (Ldlr2/2Pd12/2)
displayed striking increases in systemic CD4+ and CD8+ T cell activation after 9 weeks of high fat diet feeding, associated
with an expansion of both pro-atherogenic IFNc-secreting T helper 1 cells and atheroprotective Foxp3+ Tregs. Importantly,
PD-1 deficiency did not affect Treg suppressive function in vitro. Notably, PD-1 deficiency exacerbated atherosclerotic lesion
growth and entailed a massive infiltration of T cells in atherosclerotic lesions. In addition, aggravated hypercholesterolemia
was observed in Ldlr2/2Pd12/2 mice. In conclusion, we here demonstrate that although disruption of PD-1 signaling
enhances both pro- and anti-atherogenic T cell responses in Ldlr2/2 mice, pro-inflammatory T cell activation prevails and
enhances dyslipidemia, vascular inflammation and atherosclerosis.
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Introduction
Atherosclerosis, the major cause of myocardial infarction and
stroke, is a chronic inflammatory disease of the vascular wall
characterized by accumulation of lipid-laden macrophages in the
vascular intima [1]. It is now well accepted that local and systemic
adaptive immune responses are also a major determinant of
atherogenesis, and several CD4+ T helper (Th) cell subsets have
been shown to promote or mitigate atherosclerotic lesion
progression. While interferon (IFN)-c secreting Th1 cells promote
atherogenesis [2], Foxp3+ regulatory T cells (Treg) inhibit lesion
formation through attenuation of adaptive and innate immune
responses [3,4]. The role of other polarized T cell subsets is less
clear. The role of Th2 cells in atherogenesis remains to be
conclusively defined, as this subset was proposed to limit
atherogenesis, in part through IL-13 secretion [3], whereas other
Th2-cytokines, in particular IL-4, might be pro-atherogenic [4,2].
Likewise, IL-17-secreting Th17 cells have been proposed to both
promote and limit atherogenesis [4].
T helper cell activation during adaptive immune response,
including hypercholesterolemia-associated immunity, requires
three distinct signals, namely TCR stimulation, co-stimulatory or
-inhibitory signals, cytokine mediated potentiation or attenuation
of T cell responses [5]. It has been previously shown that co-
stimulatory molecules of the B7/CD28 and tumor necrosis factor
(TNF)/TNF receptor family are instrumental in T cell activation
during atherosclerosis [6]. Mice deficient for both B7-1 and B7-2
in atherosclerosis prone Low density lipoprotein receptor-deficient
(Ldlr2/2) mice demonstrated impaired T cell activation, and in
turn diminished atherosclerosis [7]. Antibody mediated targeting
of CD40L or CD40 deficiency in Ldlr2/2 or apolipoprotein E-
deficient (Apoe2/2) mice, respectively, similarly decreased vascular
inflammation and atherosclerosis [8,9,10].
However, also atheroprotective Treg functions depend on
similar co-stimulatory signals [6]. Ldlr2/2 mice irradiated and
reconstituted with bone marrow cells deficient in B7-1 and B7-2 or
CD28 displayed impaired Treg homeostasis and increased
atherosclerosis [8]. Although discrepancies between studies using
B7-1/2-deficient mice on a hypercholesterolemic background and
studies employing bone marrow transplantation are unexplained,
it appears that bone marrow chimerism preferentially affects Treg
activation, leading to a pro-atherogenic phenotype despite reduced
effector T cell activation. In line, chimeric Ldlr2/2 mice carrying
bone marrow deficient in Inducible Co-stimularoy Molecule
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(ICOS) displayed increased atherosclerosis, presumably associated
with decreased Treg levels, while lesion formation was not affected
in Icos2/2Ldlr2/2 double knockout mice [6,9]. Recently, Ldlr2/2
mice irradiated and reconstituted with CD11ccreMyD88flox bone
marrow, which renders dendritic cells insensitive to Toll-like
receptor-induced maturation, were shown to develop increased
atherosclerosis despite strikingly decreased T cell activation, and it
was proposed that the failure to mount adequate Treg responses
was able to overcome anti-atherogenic effects of depressed effector
T cell activation [9]. The overall outcome of co-stimulation thus
seems to represent a fine-tuned balance between activation of pro-
atherogenic effector T cell and immunomodulatory Treg respons-
es.
The co-inhibitory receptor Programmed Cell Death-1 (PD-1)
belongs to the CD28 family and is essential in T cell tolerance
[10,11]. PD-1 is expressed by T cells and binds to PD-L1 and PD-
L2, widely expressed by a number of cells at different levels
[10,11]. Of note, both PD-L1 and PD-L2 can be expressed on
activated DCs [10-12]. Although PD-1 and its ligands have been
described as an essential anti-atherogenic pathway [10,11], the
role of PD-1 in Treg homeostasis during hypercholesterolemia is
unknown. Employing Pd12/2 Ldlr2/2 mice, we here show that
Figure 1. PD-1 deficiency increases CD4+ T cell activation in hypercholesterolemic mice. a) Circulating numbers of CD4+ T cells in Ldlr2/2
or Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding. b-d) Representative FACS dot plots showing CD44 and CD62L expression in pre-gated
CD45+CD3+TCRb+ CD4+ T cells and quantitation of frequencies of CD44hiCD62L2 effector/memory cells among CD4+ T cells in blood (b), spleen (c)
and peripheral LN (d) after 9 weeks of high fat diet feeding (n = 5/group, representative of 2 independent experiments). **p,0.01.
doi:10.1371/journal.pone.0093280.g001
PD-1 Deficiency Exacerbates Atherogenesis in Mice
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deficiency in PD-1 increased T cell activation during atherogenesis
despite a strong increase in systemic Foxp3+ regulatory T cells,




Pd12/2 mice were crossed with Ldlr2/2 mice (both on a
C57BL/6J background, Jackson Laboratory), and housed under
pathogen free conditions. At 8 weeks of age, male Ldlr2/2Pd12/2and
Ldlr2/2mice were placed on an atherogenic diet (15% milk fat,
1.25% cholesterol, Altromin, Germany) for 9 weeks. All animal
experiments were approved by local authorities (Regierung von
Unterfranken, Wu¨rzburg, Germany, Akt.-Z. 55.2-2531.01-37/09) to
comply with German animal protection law.
Flow cytometry
Blood counts were analyzed using an automated hematology
analyzer (KX-21N, Sysmex, Germany). For FACS analyses,
tissues were passed through a 70 mm filter (BD Biosciences,
Germany) to obtain single-cell suspensions. Whole blood was
combined with a red blood cell lysis buffer (155 mM NH4Cl,
10 mM KHCO3, 0.1 mM EDTA) to allow the isolation of
leukocytes. Whole aortae and aortic roots were excised, flushed
with PBS, and enzymatically dissociated using Liberase Blend-
zyme TL (Roche, Germany) solution for 30 minutes at 37uC. The
resulting single cell suspensions were resuspended in Hanks
Buffered Saline Solution (HBSS), enumerated using a Neubauer
counting chamber. Cells were stained for 30 minutes on ice using
combinations of specific antibodies from BD biosciences (CD45,
clone 30-F11; CD3, clone 500A2; CD8a, clone 53-6.7; IFNc,
clone XMG1.2) and eBioscience (TCRb, clone H57-597; CD44,
clone IM7; CD62L, clone MEL-14; CD4, clone RM4-5; Foxp3,
clone FJK-16s; CD25, clone PC61.5; IL-17a, clone eBio17B7).
Intracellular labelling of IL17A and IFNc was performed using the
BD Cytofix/Cytoperm Kit (BD Biosciences). Intracellular labeling
of Foxp3 was performed using the Foxp3 Staining Buffer Set
(eBioscience) according to the manufacturer’s instructions. Probes
were analyzed using a FACSCanto II (Becton Dickson, USA) and
FlowJo 7.6 software (Treestar Inc., USA).
In vitro Treg suppression assay
Spleen and peripheral (inguinal) lymph node regulatory T cells
from Ldlr2/2 and Ldlr2/2Pd12/2 mice and naı¨ve T cells from
CD45.1 mice were enriched using magnetic microbeads
(CD4+CD25+ Regulatory T cell isolation kit, CD4+CD62L+ naı¨ve
T cell isolation kit), according to the manufacturer’s instruction
(Miltenyi Biotec, Bergisch Gladbach, Germany). Isolated naı¨ve T
cells were stained with carboxyfluorescein succinimidyl ester
(CFSE) and mixed with regulatory T cells at ratio of 2:1. Cells
were stimulated with 2.5 mg/ml rat anti-mouse CD3 (clone 145-
2C11) and 2.5 mg/ml rat anti-mouse CD28 (clone 37.51). After
48 hours, cells were washed and stained with anti-CD4 (clone
RM4-5) and anti-CD45.1 (clone A20) antibodies. Proliferation of
CD45.1 naı¨ve T cell was analyzed by CFSE dye dilution.
Assessment of atherosclerosis and immunofluorescence
Arteries were perfusion-fixed in situ with phosphate buffered
saline (PBS) followed by 4% paraformaldehyde in PBS (PFA;
Sigma Aldrich, USA). The heart and whole aorta were removed
and carefully cleaned of extraneous fat before being post-fixed in
4% PFA. The heart was embedded into paraffin and cut into 5-mm
transverse sections. Aortic root sections were assessed for
atherosclerotic plaque size after staining with Gabe’s Aldehyde
Fuchsin. Adjacent sections were used to assess plaque cellular
content by immunofluorescence staining of macrophages and
CD3+ T cells by mAb staining for Mac2 (rat anti-mouse,
Cedarlane, Canada), and CD3 (MCA1477, AbD Serotec,
Germany), respectively. Briefly, slides were blocked with 1%
bovine serum albumin (Sigma Aldrich), incubated with primary
antibody overnight at 4uC, and secondary detection using the
relevant Alexafluor 488-conjugated antibody (Molecular Probes,
Life Technologies, Germany). Sections were coverslipped using
DAPI-containing Vectashield mounting medium (Vector labora-
tories, Burlingame, USA). The extent of atherosclerosis through-
out the thoracoabdominal aorta was assessed by staining for lipid
depositions with Oil-red-O. Briefly, the thoracoabdominal aorta
was opened longitudinally, stripped of adventitia and the
percentage of lipid deposition was calculated by dividing the
stained area by the total thoracoabdominal aortic surface. All
images were recorded with a Leica DM 4000B fluorescence
microscope and JVC KY-F75U camera. Plaque size, collagen
content and cell content were quantified by computerized image
analysis (Diskus Software, Hilgers, Germany).
Serum cholesterol and triglyceride measurement
Serum was analysed for total cholesterol (Amplex Red
Cholesterol Assay Kit, Invitrogen, Life Technologies) and
Figure 2. PD-1 deficiency increases CD8+ T cell activation in
hypercholesterolemic mice. a) Circulating numbers of CD8+ T cells
in Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding.
Quantification of frequencies of CD44hiCD62L2 effector/memory cells
among CD45+CD3+TCRb+ CD8+ T cells in blood (b), spleen (c) and
peripheral LN (d) after 9 weeks of high fat diet feeding (n = 5/group).
*p,0.05.
doi:10.1371/journal.pone.0093280.g002
PD-1 Deficiency Exacerbates Atherogenesis in Mice
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triglycerides (EnzyChrom Triglyceride Assay Kit, BioAssay
Systems, USA), according to the manufacturer’s instructions.
Statistical analysis
Data are displayed as mean 6 SEM. Gaussian distribution of
values was checked using D’Agostino and Pearson Normality test.
When normality test was passed for values from both experimental
groups, an unpaired t test was performed. When normality test
failed, a non-parametric Mann-Whitney U test was performed.
Results from Treg suppression assays were analyzed by 1-way
Analysis of Variance followed by Bonferroni post-hoc test. Results
with p,0.05 were considered significant.
Results
PD-1 deficiency increases CD4+ T cell activation in blood
and secondary lymphoid organs
To investigate the role of PD-1 in T cell activation and Treg
homeostasis during hypercholesterolemia-induced atherosclerosis,
Ldlr2/2Pd12/2 deficient mice and control Ldlr2/2 mice were fed
a high fat diet for 9 weeks. At the end of this diet period, activation
of T cells was evaluated by flow cytometry staining for CD44 and
CD62L in circulating blood and single cell suspensions obtained
from spleen and peripheral (axillary and inguinal) lymph nodes
(LN). Although absolute numbers of circulating CD4+ T cells only
showed a trend towards increased levels (Figure 1a, p = 0.09), we
observed a 2.3-fold increase in the proportion of activated
CD44hiCD62L2 effector/memory cells among CD4+ T cells in
blood of Ldlr2/2Pd12/2 mice (Figure 1b). Likewise, frequencies of
CD44hiCD62L2 cells among CD4+ T cells were elevated by 1.9-
fold and 1.4-fold in the spleen and peripheral LN, respectively
(Figure 1c, d). Similarly, while circulating levels of CD8+ T cell
were unaltered between groups (Figure 2a), frequencies of
CD44hiCD62L2 effector/memory T cells were strongly increased
in blood, spleen and peripheral LN in Ldlr2/2Pd12/2 mice
compared to Ldlr2/2 controls (Figure 2b-d). These data indicate
that deficiency in PD-1 leads to widespread CD4+ and CD8+ T
cell activation in hypercholesterolemic mice.
PD-1 deficiency only moderately affects Th1/Th17
polarization but leads to systemic Treg expansion
Both Th1 cells as well as Th17 cells have been shown to
modulate the development of atherosclerosis [2,4]. We therefore
evaluated whether the activation of CD4+ T cells was associated
with a polarization towards the Th1 or Th17 lineage by staining
for intracellular IFNc (Th1) and IL17A (Th17) cytokine expres-
sion, not investigated previously. Frequencies of IFNc-producing
CD4+ T cells were unaffected but tended to be elevated in blood
Figure 3. PD-1 deficiency only slightly affects CD4+ T cell polarization towards the Th1 lineage. a) Representative FACS dot plots and
quantification of frequencies of IL-17A and IFNc-expressing cells in pre-gated CD45+CD3+TCRb+ CD4+ T cells in blood (a), spleen (b) and peripheral LN
(c) of Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding (n = 5/group, representative of 2 independent experiments). **p,0.01.
doi:10.1371/journal.pone.0093280.g003
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and spleens (Figure 3a, b), and showed a significant increase in
peripheral LN of Ldlr2/2Pd12/2 mice (Figure 3c). Levels of
IL17A-producing CD4+ T cells were unaffected by PD-1
deficiency in all organs tested (Figure 3a-c). These results
unprecedentedly indicate that PD-1 deficiency only moderately
affects systemic Th1 but not Th17-differentiation, but is associated
with a shift towards pro-atherogenic Th1 cells in peripheral LN.
Interestingly, also frequencies of atheroprotective CD25hi-
Foxp3+ Tregs [8,10] among CD4+ T cells were strongly increased
in circulating blood (Figure 4a) and spleens of Ldlr2/2Pd12/2
versus Ldlr2/2 mice (Figure 4b), while their proportions were
similar in peripheral LN (Figure 4c). These data for the first time
indicate that PD-1 deficiency entails a systemic increase in
atheroprotective Tregs.
PD-1 deficiency increases lesional activated T cell and
Treg content
Although systemic immune processes have a role in atherogen-
esis, local inflammatory T cell responses in atherosclerotic vessels
are of paramount importance in lesion formation and progression.
We thus evaluated local immune cell accumulation by immuno-
staining for T cells in cryosections through the aortic sinus.
Infiltration of CD3+ T cells in atherosclerotic plaques showed a
striking 8.2-fold increase in plaques from Ldlr2/2Pd12/2 mice
(Figure 5a, b), where T cells constituted over 20% of total plaques
cells, while they represented less than 10% in lesions of Ldlr2/2
mice (Figure 5b). In order to further obtain a more precise view of T
cell responses within lesions, aortic roots and aortae from Ldlr2/2
and Ldlr2/2Pd12/2 mice were enzymatically digested into single
cell suspensions and analyzed by flow cytometry. In line with
immunohistochemistry results, absolute numbers of CD3+ T cells
Figure 4. Treg expansion in Ldlr2/2Pd12/2mice. Representative FACS dot plots and quantification of frequencies of Foxp3 and CD25-expressing
cells in pre-gated CD45+CD3+TCRb+ CD4+ T cells in blood (a), spleen (b) and peripheral LN (c) of Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9 weeks of high
fat diet feeding (n = 5/group, representative of 2 independent experiments). *p,0.05.
doi:10.1371/journal.pone.0093280.g004
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were markedly increased in the aortic root (Figure 5c) and the aorta
(Figure 5h) in Ldlr2/2Pd12/2 versus Ldlr2/2 mice. A slight shift
from CD4+ to CD8+ T cells was noted among total CD3+ T cells in
aortic roots (Figure 5d, e) and aortae (Figure 5i, j) in Ldlr2/2Pd12/2
mice. Importantly, a significant increase in the activation of CD4+ T
cells was found in the aortic root (Figure 5f, p = 0.03) and a strong
trend towards increased activation was similarly observed in the
aorta (Figure 5k, p = 0.054). Frequencies of activated CD8+ T cells
were significantly higher in Ldlr2/2Pd12/2 aortae (Figure 5l,
p = 0.002) but unaltered in the aortic root (Figure 5g).
Notably, also Tregs accumulated to a larger extent in the aortic
root and the aorta of Ldlr2/2Pd12/2 compared to Ldlr2/2 mice.
Absolute counts of Tregs showed a drastic 6.8-fold increase in the
aortic root (Figure 6c, p = 0.004), and a strong albeit non-
significant increase in the aorta (Figure 6f, p = 0.06). Similarly,
relative Treg frequencies among CD4+ T cells were increased in
the aorta, and showed a clear trend towards increased proportions
in the aortic root. These data provide first evidence that PD-1
deficiency leads to an accumulation of activated CD4+ and CD8+
T cells also in atherosclerotic vessels, paralleled by an expansion of
Tregs.
PD-1 deficient Tregs efficiently suppress T cell
proliferation in vitro
To further investigate the functionality of PD-1-deficient Tregs,
in vitro suppression assays were performed. Ldlr2/2Pd12/2 Tregs
isolated from spleen (Figure 7a, b) or LN (Figure 7c) were equally
potent in suppressing anti-CD3/anti-CD28-induced T cell prolif-
eration as Tregs from Ldlr2/2 mice, indicating that PD-1
deficiency does not affect suppressive functions of Tregs.
PD-1 deficiency increases atherosclerosis and
hypercholesterolemia
Finally, we analyzed atherosclerotic lesion formation in Ldlr2/2
Pd12/2 mice. After 9 weeks of high fat diet feeding, atherosclerotic
plaque size was strongly increased in Ldlr2/2Pd12/2 compared to
Ldlr2/2 mice both in the aortic sinus (Figure 8a) and the aorta
(Figure 8b). Although absolute macrophage numbers per section
were increased in plaques from Ldlr2/2Pd12/2 mice, in line with
an increased lesion size, the relative proportion of Mac2+
macrophages among total plaque cells was similar between
Ldlr2/2 and Ldlr2/2Pd12/2 mice (Figure 8c). Notably, cholesterol
levels were noted to be significantly increased in serum of Ldlr2/2
Figure 5. Increased T cell infiltration and activation in atherosclerotic lesions in Ldlr2/2Pd12/2 mice. a) Representative images of anti-
CD3 immunofluorescence staining (positive cells are indicated by arrowheads) and b) quantitative analysis of CD3+ T cell numbers and frequencies
among total plaque cells in atherosclerotic plaques in the aortic sinus of Ldlr2/2 and Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding. c-l)
FACS analysis of total CD3+ T cell infiltration, CD4+ and CD8+ expressing cell proportions among total CD3+ T cells, and proportion of CD44hiCD62L2
activated cells among CD4+ and CD8+ T cells in single cell suspensions obtained from the aortic root (c-g) or the aorta (h-l) of Ldlr2/2 and Ldlr2/2
Pd12/2 mice after 9 weeks of high fat diet feeding. *p,0.05 **p,0.01.
doi:10.1371/journal.pone.0093280.g005
PD-1 Deficiency Exacerbates Atherogenesis in Mice
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Figure 6. Increased Treg infiltration in atherosclerotic lesions in Ldlr2/2Pd12/2 mice. Representative FACS dot plots (left), proportion of
CD25hiFoxp3+ Tregs among CD4+ T cells (middle) and absolute number of CD25hiFoxp3+ Tregs (right) in the aortic root (a-c) and the aorta (d-f) of
Ldlr2/2 and Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding. *p,0.05 **p,0.01.
doi:10.1371/journal.pone.0093280.g006
Figure 7. PD-1-deficient Tregs display normal suppressive function in vitro. Target naı¨ve CD4+ T cells were mixed with Ldlr2/2 or Ldlr2/2
Pd12/2 Tregs from spleen or peripheral lymph nodes at a ratio of 2:1. Representative FACS dot plots showing CD4 expression and CFSE fluorescence
in pre-gated target CD45.1+ T cells; gates P1 to P3 depict CFSE dye dilution following T cell proliferation (a). Quantitative analysis of frequencies of
target T cells in each gate after incubation with Tregs from spleen (b) or peripheral LN (c). *p,0.05 **p,0.01 ***p,0.001 vs no Tregs. Tregs from n = 3
mice per group were assessed in triplicates.
doi:10.1371/journal.pone.0093280.g007
PD-1 Deficiency Exacerbates Atherogenesis in Mice
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Pd12/2 mice, while triglyceride levels showed a non-significant
trend towards raised levels (Table 1). These results indicate that
PD-1 deficiency is associated with strongly exacerbated athero-
sclerotic lesion development, together with aggravated dyslipide-
mia.
Discussion
In the present study, we show that PD-1 deficiency leads to
widespread CD4+ T cell activation during atherogenesis, but is
also associated with a strong expansion of atheroprotective Tregs
both systemically and in atherosclerotic vessels not evidenced
previously. The net outcome of PD-1 deficiency, however, was a
markedly exacerbated atherosclerotic lesion formation in Ldlr2/2
mice. Besides providing confirmation of the critical role of PD-1
signaling in atherosclerotic lesion development, our results
highlight the complex role of co-stimulatory and co-inhibitory
pathways in controlling the balance of pro-atherogenic versus
atheroprotective T cell responses during atherogenesis.
Not unexpectedly, T cells showed a widespread activation in
atherosclerotic Ldlr2/2Pd12/2 versus Ldlr2/2 mice, as revealed by
strongly increased frequencies of CD44hiCD62L2 effector/mem-
ory cells among CD4+ and CD8+ T cells both systemically and at
atherosclerosis-prone vascular sites. These findings are in line with
previous reports in Ldlr2/2Pd12/2 [10] and Ldlr2/2Pdl1/Pdl22/2
[11] mice, and consistent with the important role of PD-1 signaling
in taming T cell activation in inflammatory and autoimmune
diseases [12]. Besides activation, polarization of T cell subsets is
critical in atherogenesis. In particular, Th1 polarization is thought
to drive disease progression both in murine models [2] and
humans [13]. CD4+ T cell polarization was only moderately
shifted towards the IFNc-producing Th1 effector T cell lineage in
specific locations, such as the spleen and peripheral LN, suggesting
a somewhat stronger pro-inflammatory and pro-atherogenic
profile. This notion is in line with previous reports, showing that
PD-1 ligation can inhibit the expression of transcription factors
involved in Th1 cell functions, including Eomes and Tbet [12],
and the increased Th1 polarization following PD-1 blockade in a
murine model of experimental autoimmune encephalomyelitis
[14]. Although PD-1 signaling has been proposed as an inhibitory
mechanism in Th17 cell differentiation [15], we did not observe
any significant modulation of Th17 polarization in atherosclerotic
Ldlr2/2Pd12/2mice. It should be noted, however, that PD-1
signaling can also affect T cell expression of other pro-atherogenic
factors, such as TNFa [12], which were not tested in our study.
Figure 8. Increased atherosclerotic lesion formation in Ldlr2/2Pd12/2 mice. a) Representative images and quantitative analysis of
atherosclerotic lesion size in the aortic sinus of Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding. b) Representative images of Oil-
Red-O stained aortae and quantitative analysis of atherosclerotic lesion size in the aorta of Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9 weeks of high fat
diet feeding (n = 8–10/group). (c) Quantitative analysis of Mac2+ monocyte/macrophage numbers and frequencies among total plaque cells in the
aortic sinus of Ldlr2/2 and Ldlr2/2Pd12/2 mice after 9 weeks of high fat diet feeding (n = 5–9/group). *p,0.05 **p,0.01 ***p,0.001.
doi:10.1371/journal.pone.0093280.g008
Table 1. Lipid levels of Ldlr2/2 or Ldlr2/2Pd12/2 mice after 9






13475 6 468 16640 6 864 ,0.01
Serum triglycerides
(mmol/L)
6.693 6 0.137 7.338 6 0.302 0.09
doi:10.1371/journal.pone.0093280.t001
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Notably, levels of CD25hiFoxp3+ Tregs were strongly increased
in Ldlr2/2Pd12/2mice after 9 weeks of high fat diet, with PD -1
deficient Tregs from various sources showed intact suppressive
functions in vitro. Previous studies have suggested differing roles of
PD-1 signaling in Treg differentiation and function. In patients
infected with Hepatitis C virus, increased PD-1 expression on
Tregs correlated with lower Treg numbers and clinical markers of
immune modulation, which in vitro could be overcome by blocking
PD-L1/PD-1 interactions [16]. Along these lines, it was demon-
strated that PD-1 and PD-L1 negatively regulate the differentia-
tion and suppressive functions of a particular Treg subset, namely
follicular Tregs [17]. However, other evidence points towards the
opposite role of PD-L1/PD-1 signaling in Treg homeostasis.
Particularly, PD-L1 has been shown to promote induced Treg
differentiation and function [18]. Discrepancies between these
reports could stem from bi-directional signaling in the PD-L1/PD-
1 pathway [12]. Besides signaling cascades triggered by PD-1 in T
cells, PD-L1, is also able to induce intracellular signaling upon PD-
1 binding, and has notably been proposed to increase anti-
inflammatory properties of dendritic cells, such as IL-10 secretion
[19]. Of note, PD-L1 is also expressed by Tregs [12], and signaling
through PD-L1 might also affect Treg expansion and function.
Moreover, besides a putative direct role of PD-1 signaling in Treg
homeostasis, PD-1 may also modulate Treg expansion through
down-modulation of CD28 or IL-2 signaling [12], required for
Treg differentiation as well as T cell activation [20,21]. In line,
CD28 signaling is critical for both effector T cell activation and
development of Treg responses during atherogenesis [8], and
results from several reports suggest that in hypercholesterolemic
mice, the extent of Treg expansion is tightly linked to the overall
extent of CD4+ T cell activation [7–9].
The outcome of PD-1 deficiency in Ldlr2/2 mice was a net
increase in vascular inflammation and atherosclerosis, suggesting
that overwhelming CD4+ and CD8+ T cell activation could not be
compensated by Treg-mediated immune modulation in hyper-
cholesterolemic Ldlr2/2Pd12/2 mice. This observation might
potentially be of importance, as it suggests that the efficiency of
therapeutic Treg expansion, which has been investigated in pre-
clinical models of atherosclerosis [20], might be hampered in an
environment highly favorable of effector T cell activation.
Importantly, we observed a striking increase in T cell infiltration
of atherosclerotic plaques in Ldlr2/2Pd12/2 mice. This might
reflect increased T cell recruitment following peripheral activation,
as well as enhanced in situ T cell proliferation and/or reduced
apoptosis, two processes that are modulated by PD-1 signaling
[12]. Previous reports have demonstrated that disruption of PD-
L1/PD-1 signaling entailes an increased accumulation of CD8+ T
cells in atherosclerotic lesions [10,11]. Our own data show a
similar shift from CD4+ to CD8+ T cells in atherosclerotic vessels
of Ldlr2/2Pd12/2 mice, associated with increased CD8+ T cell
activation in aortae, blood, spleen and lymph nodes of Ldlr2/
2Pd12/2 mice. Even though the role of CD8+ T cells in
atherogenesis has long remained enigmatic, a recent report [21]
and our own observations (Zernecke et al., unpublished data)
revealed that CD8+ T cell depletion in Apoe2/2 or Ldlr2/2 mice
reduced atherogenesis. Hence, increased CD8+ T cell activation
and infiltration into plaques likely contributes to increased
atherosclerosis in Ldlr2/2Pd12/2mice.
Besides increased vascular inflammation, we also observed
aggravated dyslipidemia in Ldlr2/2Pd12/2 mice with strongly
raised blood cholesterol and a trend towards increased triglyceride
levels. Inflammation has emerged as a major contributor to the
metabolic syndrome, including dyslipidemia [22], and evidence
indicates that the balance of regulatory and pro-inflammatory T
cell immunity affects diet-induced hyperlipidemia. For instance,
Treg depletion in mice has recently been shown to alter
lipoprotein metabolism in the liver and to promote hypercholes-
terolemia and atherosclerosis [23]. Although we observed an
expansion of Tregs in Ldlr2/2Pd12/2 mice, net effects of PD-1
deficiency seemed to clearly favor the pro-inflammatory arm of the
regulatory/pro-inflammatory T cell response, therefore one could
speculate that increased systemic T cell-dependent inflammation,
including sites such as the liver or adipose tissue, might enhance
diet-associated dyslipidemia and exacerbate atherogenesis in
Ldlr2/2Pd12/2 mice.
In conclusion, our results highlight the dual role of co-
stimulatory and co-inhibitory signals in the control of both pro-
atherogenic and atheroprotective T cell activation in hypercho-
lesterolemia, and corroborate a critical role of PD-1 signaling in
limiting atherogenesis.
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